Maria Spampinato to Brain Neoplasms
This is a "connection" page, showing publications Maria Spampinato has written about Brain Neoplasms.
Connection Strength
1.730
-
Perilesional apparent diffusion coefficient in the preoperative evaluation of glioma grade. Clin Imaging. 2018 Nov - Dec; 52:88-94.
Score: 0.458
-
Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors. AJR Am J Roentgenol. 2007 Jan; 188(1):204-12.
Score: 0.206
-
Comparison of first-pass and second-bolus dynamic susceptibility perfusion MRI in brain tumors. Neuroradiology. 2006 Dec; 48(12):867-74.
Score: 0.203
-
Dose-Lowering in Contrast-Enhanced MRI of the Central Nervous System: A?Retrospective, Parallel-Group Comparison Using Gadobenate Dimeglumine. J Magn Reson Imaging. 2021 11; 54(5):1660-1675.
Score: 0.140
-
Safety and diagnostic efficacy of gadoteridol for magnetic resonance imaging of the brain and spine in children 2?years of age and younger. Pediatr Radiol. 2021 Sep; 51(10):1895-1906.
Score: 0.139
-
Machine learning assisted DSC-MRI radiomics as a tool for glioma classification by grade and mutation status. BMC Med Inform Decis Mak. 2020 07 06; 20(1):149.
Score: 0.131
-
Early assessment of recurrent glioblastoma response to bevacizumab treatment by diffusional kurtosis imaging: a preliminary report. Neuroradiol J. 2019 Oct; 32(5):317-327.
Score: 0.123
-
Radiation intensity (CTDIvol) and visibility of anatomical structures in head CT examinations. J Appl Clin Med Phys. 2016 01 08; 17(1):293-300.
Score: 0.096
-
The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study). AJNR Am J Neuroradiol. 2015 Sep; 36(9):1589-98.
Score: 0.093
-
Correlation between cerebral blood volume measurements by perfusion-weighted magnetic resonance imaging and two-year progression-free survival in gliomas. Neuroradiol J. 2013 Aug; 26(4):385-95.
Score: 0.082
-
Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease? AJNR Am J Neuroradiol. 2009 Apr; 30(4):681-8.
Score: 0.060